[Event report] Global Expert Meeting to Commemorate the Establishment of AMR Alliance Japan (November 08, 2018)
date : 11/13/2018
Tags: AMR
******* The Final Report has been published on April 11, 2019 .
For more information, please refer to the PDF.
Every year, Antimicrobial Resistance (AMR) kills approximately 700,000 people globally. The magnitude of this issue drove the WHO to adopt a Global Action Plan on AMR during its May 2015 World Health Assembly. That action plan called upon member states to reinforce measures against AMR and draw up their own national action plans. In addition to those efforts, many countries have been working to establish alliances on this issue. Such momentum for international collaboration must be sustained. It is hoped that measures against AMR will be included in the agenda of the upcoming G20 Osaka Summit to be held in June 2019.
In Japan, AMR has become a major challenge for many medical facilities, with cases of community-acquired drug-resistant infections on the rise nationally. Japan enacted its National Action Plan on Antimicrobial Resistance in April 2016. Sensing the growing concern about AMR domestically and abroad, HGPI has taken the initiative to host three expert meetings on this subject since 2016. The 1st expert meeting, “Japan’s Role in Addressing Global Antimicrobial Resistance” brought together actors from the Government, academia, and industry for a debate on policy. The 2nd meeting produced “Seven Recommendations for Promoting Measures Against AMR.” The 3rd meeting coincided with World Antibiotic Awareness Week, and again brought together stakeholders from the Government, academia, and industry for a discussion on Japan’s national action plan, concrete obstacles to its implementation, and measures to overcome those obstacles. In September 2018, HGPI convened the AMR Alliance Japan Kick-off Meeting to discuss the vision for AMR Alliance Japan and further promote policies on AMR based on the conversations in the previous three expert meetings.
To commemorate the official establishment of AMR Alliance Japan, HGPI hosted a global expert meeting featuring representatives from academia, the Government, industry, and civil society. Based on the issues raised during the Kick-off Meeting, participants debated and defined the concrete initiatives that the Alliance should undertake on matters such as the revision of the medical fee system in order to promote rapid diagnostic technology, guidelines on the proper use of antimicrobials for both medical personnel and the public, the creation of an AMR surveillance data repository, the founding of a Japanese consortium for drug discovery, and the promotion of incentives for stimulating drug development.
――――
Explanatory Introduction
Ryoji Noritake (CEO, Board Member, HGPI)
Welcome Remarks
Kiyoshi Kurokawa (Chairman, HGPI) *Video address
Keynote Address
Kuniaki Miyake (Director, Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare)
Panel Discussion 1 – Expectations for AMR Alliance Japan Policy Recommendations
Panelists:
- Satoshi Kamayachi (Executive Board Member, Japan Medical Association)
- Hiroshi Kiyota (President, Japanese Society of Chemotherapy /Professor, Department of Urology, The Jikei University Katsushika Medical Center)
- Jenelle S. Krishnamoorthy (Associate Vice President, Global Policy, Communications and Population Health, Merck & Co.)
- Takuko Sawada (Director of the Board, Vice President, Corporate Strategy Dvision, Shionogi & Co., Ltd.)
- Kazuhiro Hamaji (Nippon Becton Dickinson Company, Ltd.)
Moderator:
- Matt McEnany (Manager, HGPI)
Panel Discussion 2 – Multi-stakeholder Cooperation on AMR Policies
Panelists:
- Kyoko Ama (Representative, Ippan Shadan Hojin Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai)
- Kazuhiro Tateda (President, The Japanese Association for Infectious Diseases / President, The Japanese Society for Clinical Microbiology / Professor, Department of Microbiology and Infectious Diseases, Toho University)
- Yasunori Tawaragi (Director, International Affairs, Japan Pharmaceutical Manufacturers Association)
- Kuniaki Miyake (Director, Tuberculosis and Infectious Diseases Control Division, Ministry of Health, Labour and Welfare)
Moderator:
- Manami Takamatsu (Manager, HGPI)
Closing Remarks
Mitsuo Kaku (President, The Japanese Society for Infection Prevention and Control/ Professor, Infection Control and Laboratory Diagnostics, Internal Medicine, Department of Medical Sciences, Graduate School of Medicine, Tohoku University)
The event report will be uploaded at a later time.
Following this expert meeting, HGPI will host a “2019 preparatory meeting for the Alliance’s tasks and activities (roundtable discussion).”
The founding of the Alliance was featured on the World Health Organization’s (WHO) webpage about its Antimicrobial Resistance Awareness activities, available on the below link.
WHO website: Global Expert Meeting to Commemorate the Establishment of AMR Alliance Japan
(No particular order, titles omitted)
(Photographed by: Kazunori Izawa)
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)